What happens to your data if 23andMe collapses? - Harvard GazetteRegulation is essential to protect personal and genetic data amidst uncertainties in biotech firms like 23andMe.
23andMe appoints new board members as it works to stem the company's slide23andMe appointed three new independent directors after all previous members resigned, highlighting challenges including consumer privacy concerns and declining stock values.
What happens to your data if 23andMe collapses? - Harvard GazetteRegulation is essential to protect personal and genetic data amidst uncertainties in biotech firms like 23andMe.
23andMe appoints new board members as it works to stem the company's slide23andMe appointed three new independent directors after all previous members resigned, highlighting challenges including consumer privacy concerns and declining stock values.
Calif. tech companies see laid-off workers as 'table scraps,' recruiters sayJob seekers who mention recent layoffs often face implicit biases that can negatively impact their job interview outcomes.
BioMarin continues wave of California biotech layoffs with 128 more cutsBioMarin Pharmaceutical is laying off 225 employees as part of an organizational redesign due to financial pressures from gene therapy projects.
Calif. tech companies see laid-off workers as 'table scraps,' recruiters sayJob seekers who mention recent layoffs often face implicit biases that can negatively impact their job interview outcomes.
BioMarin continues wave of California biotech layoffs with 128 more cutsBioMarin Pharmaceutical is laying off 225 employees as part of an organizational redesign due to financial pressures from gene therapy projects.
3 GLP-1 Stocks to Buy Now For Big Long-Term GainsWeight loss drug market shows impressive growth, driven by GLP-1 agonists.New potential applications for these drugs could significantly expand the market.Positive investor sentiment around biotech companies focused on weight loss drugs.
See the top 10 highest-paid CEOs in Mass., according to the Boston Business JournalMassachusetts' top-paid CEO Sumit Singh of Chewy Inc. earned over $35 million in compensation last year.
Moderna's mRNA dreams meet reality with first post-Covid shotThe upcoming RSV shot by Moderna showcases the potential of mRNA technology to treat various illnesses beyond Covid.
Allozymes puts its accelerated enzymatics to work on a data and AI play, raising $15M | TechCrunchAllozymes raised a $15 million series A to expand its enzyme-screening business from service to resource.